Figure 5.
In vitro anticancer efficacy of MNs on B16F10 cells. A. Timeline and schematic of 2D B16F10 melanoma model study via MN arrays patch. B.CCK-8 assay for quantitatively evaluation of cell viability treated by MNs-0, MNs-15, and MNs-30. C. Live/Dead assay for 2D B16F10 cells treated with MNs-0, MNs-15, and MNs-30; control was with no treatment (Scale bar: 100 μm).